Document is current
Any future updates will be listed below
-
Authors
Raphenya, Amogelang R.
Robertson, James https://orcid.org/0000-0002-8534-5694
Jamin, Casper https://orcid.org/0000-0003-0244-0467
de Oliveira Martins, Leonardo https://orcid.org/0000-0001-5247-1320
Maguire, Finlay
McArthur, Andrew G. https://orcid.org/0000-0002-1142-3063
Hays, John P. https://orcid.org/0000-0001-9183-4497
-
Funding
Funding for this research was provided by:
Quadram Institute Bioscience (BB/CCG1860/1)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-156214)
Joint Programming Initiative on Antimicrobial Resistance (549010001)
- License Information
-
More Information
Article History
Received: 14 February 2022
Accepted: 10 June 2022
First Online: 15 June 2022
Competing interests
: The authors declare no competing interests. L.de.O.M was funded by the Quadram Institute Bioscience BBSRC funded Core Capability Grant (project number BB/CCG1860/1). A.R.R and A.G.M. were supported by a grant from the Canadian Institutes of Health Research (PJT-156214) and A.G.M. was additionally supported by a David Braley Chair in Computational Biology. F.M. was funded by the Dalhousie University and Sunnybrook Health Sciences Centre. C.J. was funded by the Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center. J.P.H was funded by a Network Plus 2020 grant from the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR - Seq. 4AMR - ZonMW 549010001) and the Erasmus University Medical Centre Rotterdam (Erasmus MC). No additional funding was required for the work described in this manuscript.
